Following the reception of its FDA Clearance for its IB3D™ range of 3D-printed Titanium interbody devices, Medicrea recently acquires three patents from Dr. Paul McAfee, of University of Maryland St. Joseph’s Medical Center.  These patents cover the methodology used to measure and plan interbody devices used in spinal surgery.


The three patents enable Dr. McAfee to protect the associated intellectual property around a novel technique for physiologically selecting interbody device height based on patient anatomy; the goal being to improve Medicrea’s UNiD™ ASI platform in safety conditions.

The approach with 3D printing

The acquisition of these patents makes Medicreas methodology with engineering services and in-house 3D-Printing capabilities, the unique way to deeply collaborate with surgeons to create interbody device solutions that are adapted to their clinical and mechanical preferences.

Indeed, as demonstrated by the recent FDA clearance,  these interbody devices are made by IB3D™ with complete in-house additive manufacturing capabilities and total control of the internal process without any of the limitations associated with subcontracting external suppliers.

Dr. McAfee stated, “Medicrea is uniquely positioned to benefit from this intellectual property to enhance their industry-leading surgical planning service. Surgeons understand that the effective use of interbody devices plays an important role in determining outcomes for spinal patients and spend significant time intra-operatively testing for the ‘best-fitting’ interbody device based on a limited range of dimensions provided by legacy manufacturers. However, this current technique often leads to compromise between two available interbody dimensions and lacks scientific rationale. Knowing the level of inventory required to deliver a range meeting patient needs in every case is cost-prohibitive for even the largest legacy manufacturers. There is a clear demand for the reliable planning tools and services available with UNiD™ ASI.

Denys Sournac, President and Chief Executive Officer, stated, “We are focused on fully integrating the important work done by Dr. McAfee into our proprietary UNiD™ HUB surgical planning software. Combining data-driven planning techniques with the ability to deliver personalized implants will significantly reduce the inventory required for each case while ensuring the optimal implant is provided for the patient at each level operated. Acquiring new planning methodologies, as we have done with Dr. McAfee, will allow Medicrea to further provide healthcare shareholders with scientific evidence supporting the surgical strategy and promoting a cost-effective care continuum in line with our Adaptive Spine Intelligence™ technology.”


For further information about 3D Printing, follow us on our social networks and subscribe to our newsletter!